Health Catalyst: Q3 Earnings Insights
Shares of Health Catalyst (NASDAQ:HCAT) rose 2.39% in after-market trading after the company reported Q3 results.
Quarterly Results
Earnings per share rose 22.22% over the past year to ($0.21), which beat the estimate of ($0.27).
Revenue of $47,191,000 up by 19.70% from the same period last year, which beat the estimate of $44,590,000.
Guidance
Earnings guidance hasn't been issued by the company for now.
The upcoming fiscal year's revenue expected to be between $186,100,000 and $189,100,000.
Conference Call Details
Date: Nov 10, 2020
Time: 05:00 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/hb94z5mg
Technicals
52-week high: $41.26
Company's 52-week low was at $17.48
Price action over last quarter: Up 13.39%
Company Description
Health Catalyst Inc is engaged in providing data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, which is the key revenue driver, includes data platform, analytics applications and support services. This generates revenues primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; and Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See more from Benzinga
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
